Transcription initiation of genes associated with azole resistance in Candida albicans

J B Harry1, J L Song, C N Lyons

  • 1Department of Pathobiology, School of Public Health and Community Medicine, University of Washington and the Seattle Biomedical Research Institute, 98109-1651, USA.

Medical Mycology
|February 28, 2002
PubMed

Insights

Drug-resistant Candida albicans oral infections are increasing in immunosuppressed patients. Researchers identified transcription initiation sites for key multidrug resistance genes (CDR1, CDR2, MDR1, ERG11) to understand resistance mechanisms.

Area of Science:

  • Mycology
  • Molecular Biology
  • Infectious Diseases

Background:

  • Oral infections by Candida albicans are common in immunosuppressed individuals.
  • Emergence of drug-resistant strains due to azole antifungal use is a significant clinical challenge.
  • Multidrug resistance in Candida albicans is linked to efflux pumps (MDR1, CDR1, CDR2) and target enzyme alterations (ERG11).

Purpose of the Study:

  • To identify transcription initiation sites for genes (CDR1, CDR2, MDR1, ERG11) involved in Candida albicans multidrug resistance.
  • To facilitate further investigation into the transcriptional regulation of these resistance-associated genes.
  • To provide foundational data for developing strategies against azole-resistant fungal infections.

Main Methods:

  • Utilized 5' rapid amplification of cDNA ends (RACE) to map transcription start sites.
  • Confirmed identified transcription initiation sites through cloning and sequencing of 5' RACE products.
  • Employed primer extension assays to validate the transcription start sites.

Main Results:

  • Successfully identified the transcription initiation sites for CDR1, CDR2, MDR1, and ERG11 genes.
  • Confirmed the accuracy of these findings through complementary molecular techniques.
  • Established precise locations of gene promoters critical for multidrug resistance.

Conclusions:

  • The identification of transcription initiation sites is crucial for understanding the regulatory mechanisms of multidrug resistance in Candida albicans.
  • This research provides essential data for future studies on gene expression control in antifungal resistance.
  • Understanding transcriptional regulation can pave the way for novel therapeutic approaches against resistant fungal pathogens.

Related Concept Videos

Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Transcription Attenuation in Prokaryotes02:42

Transcription Attenuation in Prokaryotes

Transcriptional attenuation occurs when RNA transcription is prematurely terminated due to the formation of a terminator mRNA hairpin structure.  Bacteria use these hairpins to regulate the transcription process and control the synthesis of several amino acids including histidine, lysine, threonine, and phenylalanine. Transcription attenuation takes place in the non-coding regions of mRNA.
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...